Healthcare & Life Sciences
GABA Therapeutics
United Statesgabarx.com/
GABA Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B.
Activeseries-b
series-b
Stage
About GABA Therapeutics
GABA Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.
GABA Therapeutics is a mid-stage biotechnology company developing GRX-917, a deuterated analog of an anxiety medication that aims to provide benzodiazepine-like efficacy with reduced addiction risk by increasing endogenous neurosteroids and inhibiting NLRP3 inflammation.
Explore GABA Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.